A组链球菌疫苗研究进展(4)
[11]Steer AC， Law I， Matatolu L， Beall BW， Carapetis JR Global emm type distribution of group A streptococci： systematic review and implications for vaccine development Lancet Infect Dis， 2009， 9 (10)： 611616
[12]Dale JB， Niedermeyer SE， Agbaosi T， Hysmith ND， Penfound TA， Hohn CM， Pullen M， Bright MI， Murrell DS， Shenep LE， Courtney HS Protective immunogenicity of group A streptococcal Mrelated proteins Clin Vaccine Immunol， 2015， 22 (3)： 344350
, 百拇医药
[13]Courtney HS， Niedermeyer SE， Penfound TA， Hohn CM， Greeley A， Dale JB Trivalent Mrelated protein as a component of next generation group A streptococcal vaccines Clin Exp Vaccine Res， 2017， 6 (1)： 4549
[14]Batzloff M， Yan H， Davies M， Hartas J， Good M Preclinical evaluation of a vaccine based on conserved region of M protein that prevents group A streptococcal infection Indian J Med Res， 2004， 119 Suppl： 104107
[15]Pandey M， Wykes MN， Hartas J， Good MF， Batzloff MR Longterm antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help J Immunol， 2013， 190 (6)： 26922701
, 百拇医药
[16]Batzloff MR， Fane A， Gorton D， Pandey M， RiveraHernandez T， Calcutt A， Yeung G， Hartas J， Johnson L， Rush CM， McCarthy J， Ketheesan N， Good MF Preclinical immunogenicity and safety of a Group A streptococcal M proteinbased vaccine candidate Hum Vaccin Immunother， 2016，12(12)： 30893096
[17]Guilherme L， Postol E， Ferreira FM， DeMarchi LM， Kalil J Strept In Cor： a model of antiStreptococcus pyogenes vaccine reviewed Auto Immun Highlights， 2013， 4 (3)： 8185
, 百拇医药
[18]Guilherme L， Ferreira FM， Khler KF， Postol E， Kalil J A vaccine against Streptococcus pyogenes： the potential to prevent rheumatic fever and rheumatic heart disease Am J Cardiovasc Drugs， 2013， 13 (1)： 14
[19]Marshall HS， Richmond P， Nissen M， Lambert S， Booy R， Reynolds G， Sebastian S， Pride M， Jansen KU， Anderson AS， Scully IL Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in Australia Pediatr Infect Dis J， 2015， 34 (8)： 831838
, 百拇医药
[20]Cleary PP， Matsuka YV， Huynh T， Lam H， Olmsted SB Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice Vaccine， 2004， 22 (3132)： 43324341
[21]Steer AC， Batzloff MR， Mulholland K， Carapetis JR Group A streptococcal vaccines： facts versus fantasy Curr Opin Infect Dis， 2009， 22 (6)： 544552, 百拇医药(吴永祥 王嘉睿 刘金来)
[12]Dale JB， Niedermeyer SE， Agbaosi T， Hysmith ND， Penfound TA， Hohn CM， Pullen M， Bright MI， Murrell DS， Shenep LE， Courtney HS Protective immunogenicity of group A streptococcal Mrelated proteins Clin Vaccine Immunol， 2015， 22 (3)： 344350
, 百拇医药
[13]Courtney HS， Niedermeyer SE， Penfound TA， Hohn CM， Greeley A， Dale JB Trivalent Mrelated protein as a component of next generation group A streptococcal vaccines Clin Exp Vaccine Res， 2017， 6 (1)： 4549
[14]Batzloff M， Yan H， Davies M， Hartas J， Good M Preclinical evaluation of a vaccine based on conserved region of M protein that prevents group A streptococcal infection Indian J Med Res， 2004， 119 Suppl： 104107
[15]Pandey M， Wykes MN， Hartas J， Good MF， Batzloff MR Longterm antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help J Immunol， 2013， 190 (6)： 26922701
, 百拇医药
[16]Batzloff MR， Fane A， Gorton D， Pandey M， RiveraHernandez T， Calcutt A， Yeung G， Hartas J， Johnson L， Rush CM， McCarthy J， Ketheesan N， Good MF Preclinical immunogenicity and safety of a Group A streptococcal M proteinbased vaccine candidate Hum Vaccin Immunother， 2016，12(12)： 30893096
[17]Guilherme L， Postol E， Ferreira FM， DeMarchi LM， Kalil J Strept In Cor： a model of antiStreptococcus pyogenes vaccine reviewed Auto Immun Highlights， 2013， 4 (3)： 8185
, 百拇医药
[18]Guilherme L， Ferreira FM， Khler KF， Postol E， Kalil J A vaccine against Streptococcus pyogenes： the potential to prevent rheumatic fever and rheumatic heart disease Am J Cardiovasc Drugs， 2013， 13 (1)： 14
[19]Marshall HS， Richmond P， Nissen M， Lambert S， Booy R， Reynolds G， Sebastian S， Pride M， Jansen KU， Anderson AS， Scully IL Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in Australia Pediatr Infect Dis J， 2015， 34 (8)： 831838
, 百拇医药
[20]Cleary PP， Matsuka YV， Huynh T， Lam H， Olmsted SB Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice Vaccine， 2004， 22 (3132)： 43324341
[21]Steer AC， Batzloff MR， Mulholland K， Carapetis JR Group A streptococcal vaccines： facts versus fantasy Curr Opin Infect Dis， 2009， 22 (6)： 544552, 百拇医药(吴永祥 王嘉睿 刘金来)